I[mmediately]{.smallcaps} upon synthesis, pre-messenger RNA (pre-mRNA)^1^ molecules associate with proteins to form heterogeneous nuclear ribonucleoprotein particles (hnRNPs) ([@B20]). The predominant hnRNP proteins remain bound to the transcripts while these reside in the nucleus. When the processed transcripts leave the nucleus through the nuclear pores, some of the hnRNP proteins are displaced from the transcripts, while others accompany the transcripts into the cytoplasm ([@B60]; [@B16]). For a long time, no specific function could be assigned to the hnRNP proteins, but substantial information has now accumulated suggesting that they play crucial roles in pre-mRNA splicing as well as in the transport of mature mRNA into the cytoplasm.

The hnRNP proteins are among the most abundant in the cell nucleus ([@B48]). In human, the hnRNP particles contain more than 20 major protein species, designated hnRNP A1 to hnRNP U ([@B61]). In *Drosophila*, more than 10 of the predominant hnRNP proteins have been found and characterized, some of them showing high homology to the human proteins (e.g., [@B30]; [@B2]; [@B43]). The hnRNP proteins have a modular structure containing one or more RNA-binding motifs and an auxiliary domain ([@B20]). The predominant RNA-binding domain (RBD) is composed of 90--100 amino acids and is usually called the RNP consensus RBD or the RNA recognition motif; within this sequence, there is a highly conserved octapeptide, RNP-1, and a hexapeptide, RNP-2. Several of the most abundant hnRNP proteins, e.g., hnRNP A1, have a glycine-rich auxiliary domain and are designated RBD-Gly proteins ([@B20]).

The hnRNP proteins are added to the growing RNA transcript concomitant with transcription (Economides and Pederson, 1983; [@B44]; [@B80]), and an RNP fibril is immediately formed ([@B50]; [@B70]; [@B22]). If the transcript is long, the fibril is further folded into a compact RNP particle ([@B51]; [@B71]). The packing of the transcript into an RNP fibril or RNP particle could be important to ensure efficient transport and a minimum of irrelevant interactions and entanglements. Furthermore, the RNP complex is organized in a nonrandom manner. The various hnRNP proteins bind to RNA in a sequence-dependent manner (for review see [@B20]) and are, therefore, likely to appear in a specific arrangement along an hnRNA molecule. In addition, when the basic RNP fibril is further folded, the RNP particles attain a characteristic shape ([@B41]; [@B71]). Thus, the RNA molecule is organized in a specific way in the RNP complexes, presumably exposing certain sequences for molecular interactions while others are likely to be hidden in the complex.

The hnRNP proteins are important to accomplish proper splicing of pre-mRNA. The splicing takes place on the growing RNP complex ([@B55]; [@B7]; [@B39]; [@B5]) or on the completed RNP product released from the template ([@B53]; see also [@B5]). It was shown early on that antibodies to hnRNP proteins can block splicing in vitro, suggesting that the hnRNP proteins are involved in the splicing reaction ([@B15]; [@B68]). There is growing evidence suggesting that SR proteins, an extensively studied family of splicing factors, could also be regarded as constitutive components of the RNP complex rather than as spliceosome components that are assembled and disassembled in conjunction with splicing ([@B1]; see also [@B13]). Like the classical hnRNP proteins, the SR proteins contain one or more RNA-binding domains of the RNP consensus type and an auxiliary domain ([@B8]; [@B25]). The auxiliary domain of the SR proteins is characterized by a series of serine-arginine dipeptides (SR domain). The SR proteins are essential splicing factors, which can often also regulate alternative splicing (for reviews see [@B25]; [@B42]; [@B76]). They not only take part in establishing the early commitment complex but also participate in later stages of the splicing process. The main role of the SR proteins seems to be to form molecular bridges between essential components of the spliceosome. It is interesting to note that hnRNP A/B proteins and SR proteins act antagonistically in the regulation of alternative splicing in vitro ([@B45]; [@B46]). Presumably, the various SR proteins have different functions and/or targets during splicing (e.g., [@B42]), and at least some of them are likely to play a regulatory role during development ([@B64]).

The hnRNP proteins are also directly involved in the transport process. It has been revealed that hnRNP A1, which shuttles between the nucleus and the cytoplasm ([@B60]), contains a nuclear export signal (NES) ([@B47]). It has also been demonstrated for an hnRNP A1 homologue that it leaves the nucleus still associated with mRNA ([@B78]). Taken together, this information strongly supports the proposition that the export signal in hnRNP A1 mediates not only the export of A1 itself but also the exit of the entire mRNP complex ([@B60]). Recent microinjection experiments have further strengthened the notion that the A1 NES plays a role in the export of mRNA; however, the export of other classes of RNA remains unaffected ([@B32]). It seems likely that the NES domain of A1 interacts with a soluble export receptor because such receptors, designated exportins and involved in the export of proteins with leucine-rich NESs (including the Rev protein), have recently been identified ([@B23]; [@B26]; [@B73]). An A1-interacting protein called transportin mediates the reentry of A1 into the nucleus ([@B62]; [@B24]), but it is uncertain whether it is also the RNP export receptor looked for ([@B32],*b*; [@B69]). It should be added that a putative export signal different from the A1 NES has recently been identified in hnRNP K ([@B49]). Because hnRNP A1 and hnRNP K are likely to be bound to the same transcript and both in many copies, the transport machinery for mRNP could be quite complex.

Finally, the hnRNP proteins could be involved in active retention of mRNAs in the nucleus. The nonshuttling hnRNP proteins, e.g., hnRNP C1, C2, and U ([@B59], [@B60]), are stripped off from RNP particles before mRNA is transported into the cytoplasm. A 78--amino acid--long nuclear retention signal has been discovered in the auxiliary domain of hnRNP C1 ([@B52]). This nuclear retention signal can override nuclear export signals in the shuttling hnRNP proteins, and therefore, the nonshuttling proteins have to be actively removed from the hnRNP complex before the nucleocytoplasmic translocation.

The hnRNP complexes bind to and pass through the nuclear pore complex (NPC) in an ordered, multistep process ([@B16]). The NPC consists of a spoke assembly sandwiched between a nuclear and a cytoplasmic ring (for recent review see [@B56]). In the center of the NPC, there is a plug containing a central, transport-mediating channel. In addition, nuclear fibers extend from the nuclear ring into the nucleoplasm, forming a well- defined basket structure, and cytoplasmic fibers anchored in the cytoplasmic ring reach into the cytoplasm. The RNP complexes bind to the nuclear basket, are transferred to the entrance of the central channel, and translocate through the channel ([@B16]; [@B57]). On the cytoplasmic side, they enter the cytoplasm with no obvious contact with the cytoplasmic fibers. Before or in conjunction with the passage through the NPC, the hnRNP complexes lose the nonshuttling proteins ([@B60]; [@B1]), while the shuttling ones seem to remain attached to the RNA molecule ([@B78]). Our knowledge of the molecular structure of the NPC is rapidly increasing ([@B19]; [@B54]), but there is still only limited information at the molecular level on the nature of the initial binding of the mRNP to the NPC and the further translocation of the particle through the NPC.

To further elucidate the structure of the hnRNP complexes and the function of the various hnRNP proteins involved, it is a great advantage to be able to analyze a specific pre-mRNP complex. The Balbiani ring (BR) pre-mRNP particles in the salivary glands of the dipteran *Chironomus tentans* offer such a possibility ([@B16]). By electron microscopy, it is possible to follow how the BR pre-mRNP particle is assembled along a gene, and how the released BR pre-mRNP particle is transported in the nucleoplasm to and through a nuclear pore. It has been possible to define a series of discrete steps during the passage of the particle through the NPC and to reveal drastic conformational changes of the particle during the translocation. Furthermore, the fate of defined hnRNP proteins in the BR particles can be investigated by immunoelectron microscopy. Two hnRNP proteins, hrp36 and hrp45, have been analyzed in detail ([@B80]). The hrp36 protein shows high homology to human hnRNP A1 and *Drosophila* hrp40 ([@B78]). It is being added to BR particles concomitant with transcription and accompanies the BR-mRNA through the nuclear pore and ends up with mRNA in polysomes in cytoplasm. The hrp45 protein is an SR protein and is similar to the human splicing factor SF2/ASF and *Drosophlia* SRp55/B52 ([@B1]). This protein is confined to the nucleus and is released when the particle enters the central channel of the nuclear pore complex.

In the present study, we have identified a third hnRNP protein in the BR particles, hrp23, and determined its fate. This protein contains one RNA-binding domain and a glycine-arginine-serine--rich auxiliary domain. It is being added to the BR transcript concomitant with transcription and is released from the BR particle just before or at the binding of the particle to the nuclear pore complex, i.e., hrp23 is shed late but still clearly before hrp45, the nonshuttling protein earlier studied. It seems likely, therefore, that there is not a single protein-removal step at nucleocytoplasmic transport but rather a series of preparatory steps before the actual translocation of the RNP particle through the pore. We conclude that each hnRNP protein seems to have a specific flow pattern during nucleocytoplasmic transport, presumably coupled to the particular function of the protein. It should finally be added that unlike hrp36 and hrp45, hrp23 is present also in the nucleoli.

Materials and Methods {#MaterialsMethods}
=====================

Culturing Conditions and Drug Treatments
----------------------------------------

*C*. *tentans* was cultured as described by [@B40], and salivary glands were isolated from fourth instar larvae. *C*. *tentans* tissue culture cells were grown in suspension at 24°C as previously described ([@B81]). In actinomycin D treatments, the cells were first incubated for 30 min in fresh medium containing 50 μg/ml cycloheximide. The actinomycin D was subsequently added to the culture at a final concentration of 5 μg/ml, and the incubation continued for an additional 60 min. In all cases, control cells were incubated in parallel in fresh medium without drugs.

Preparation of RNP Extract from C. tentans Tissue Culture Cells
---------------------------------------------------------------

The RNP extract was prepared as earlier described ([@B80]). In short, *C*. *tentans* tissue culture cells were washed in PBS (137 mM NaCl, 3 mM KCl, 8 mM Na~2~HPO~4~, and 2 mM NaH~2~PO~4~, pH 7.2), resuspended in TNM (10 mM triethanolamine-HCl, pH 7.0, 100 mM NaCl, and 1 mM MgCl~2~) containing 0.2% NP-40 and 0.1 mM PMSF, homogenized in a glass tissue grinder with a tight-fitting pestle, and centrifuged at 2,000 *g* for 5 min at 4°C. The pellet, containing the nuclei, was resuspended in TNM provided with *E*. *coli* tRNA (0.1 mg/ml), sonicated, and centrifuged at 7,000 *g* for 10 min at 4°C. The supernatant, designated the RNP extract, was used for immunoprecipitation of hnRNP complexes and for Western blot analysis.

Generation of Monoclonal Antibody 1D3
-------------------------------------

The 1D3 antibody is a mouse mAb obtained from spleen cells of BALB/c mice immunized with *C*. *tentans* hnRNP proteins as follows:

### Immunoprecipitation of hnRNP Complexes from C. tentans RNP Extract.

hnRNP complexes were immunoprecipitated from the RNP extract essentially as described by [@B80]. Tissue culture cells from 500 ml of medium were used to prepare 4 ml of the RNP extract (in TNM). The RNP extract was supplemented with NP-40 to a final concentration of 0.1% and mAb 4F9 (an anti-hrp36 antibody) to 20 μg/ml. The mixture was incubated at 4°C with gentle rotation. After 90 min of incubation, 100 μl of rabbit anti--mouse immunoglobulin coupled to protein A--Sepharose was added to the mixture, and the incubation continued at 4°C for an additional 90 min. The immunoglobulin--protein A--Sepharose complex was prepared according to [@B80]. Once the incubation was finished, the Sepharose resin was sedimented, washed twice with TNM containing 0.1% NP-40, and washed once with TNM. The immunoprecipitated material was finally eluted from the resin with 0.5% SDS in water. The eluted proteins were precipitated with cold acetone and resuspended in PBS. This procedure gave 25--50 μg of hnRNP proteins as judged from Coomassie blue--stained SDS-PAGE gels.

### Immunization of BALB/c Mice.

The immunization was carried out following standard procedures as described by [@B29]. Approximately 15--20 μg of hnRNP proteins, dissolved in PBS, were mixed with complete Freund adjuvant and injected intraperitoneally to BALB/c mice. Three boost injections with the same amount of antigen in incomplete adjuvant were given in 2-wk intervals. 10 d after the last boost, the sera of the immunized mice were tested by Western blot analysis to detect antibodies against *C*. *tentans* proteins. The mouse that gave the strongest response received an intravenous injection of antigen in PBS without adjuvant.

### Fusion and Screening of Suitable mAbs.

3 d after the last injection, the spleen of the immunized mouse was macerated, and the spleen cells were fused with mouse myeloma Sp20 cells in the presence of poly-ethylene-glycol 4000 (GIBCO-BRL, Life Technologies, Inc., Grand Island, NY). The fused cells were plated onto 96-well plates and cultured in Optimum medium. The standard hypoxanthine-aminopterin-thymidine (HAT) selection procedure was applied to select the hybridoma clones ([@B29]). The media from wells with growing cells were tested by Western blot analysis against *C*. *tentans* RNP extracts. To select antibodies binding to Balbiani rings, the media were also tested by immunostaining of polytene chromosome squashes ([@B79]). Cells from the positive wells were cloned at least three times by limiting dilution. The mAb 1D3, which recognized a 23-kD protein and bound to BRs, was chosen for further analysis.

SDS-PAGE and Western Blot Analysis
----------------------------------

The proteins in the RNP extract were precipitated with cold acetone, resuspended in sample buffer (10% glycerol, 2% SDS, 10 mM DTT, 0.02% bromophenol blue, and 0.0625 M Tris-HCl, pH 6.8), and separated by electrophoresis in a 10% polyacrylamide gel containing 0.1% SDS. After electrophoresis, the proteins were blotted to transfer membranes (Immobilon-P; Millipore Corp., Bedford, MA) using a Trans-Blot semidry electrophoretic system (Bio-Rad Laboratories, Hercules, CA). Membranes were blocked in PBS containing 10% dry milk powder for 1 h and incubated with primary antibodies diluted in PBS containing 1% dry milk powder and 0.05% Tween-20. Labeling was visualized with alkaline phosphatase--conjugated anti--mouse immunoglobulin (DAKO A/S, Glostrup, Denmark) using the NBT/BCIP system (Promega Corp., Madison, WI).

Immunostaining of Polytene Chromosomes
--------------------------------------

Salivary glands were isolated from fourth instar larvae and prefixed for 90 s at room temperature in 2% paraformaldehyde in TKM (100 mM KCl, 1 mM MgCl~2~, and 10 mM triethanolamine-HCl, pH 7.0). The prefixed glands were washed in cold TKM for 5 min, kept for 60 s in TKM buffer containing 2% NP-40, and transferred into 0.025% NP-40 in TKM. The subsequent isolation of the polytene chromosomes was performed on a cold stage close to 0°C. Under a stereomicroscope, the glands were repeatedly sucked in and out of a micropipette with a narrow opening (bore diameter 250 μm) to release polytene chromosomes. Single chromosomes were identified and transferred with a pipette into a drop of TKM placed on a siliconized glass slide (for details see [@B9]). The NP-40-- containing solution was exchanged with fresh TKM to get the chromosomes to stick to the surface of the glass slide. The isolated polytene chromosomes were postfixed with 4% paraformaldehyde in TKM for 30 min at room temperature and washed three times with fresh TKM. Subsequently, they were used immediately for the immunocytological analysis.

For preparation of RNase-treated chromosomes, the isolated polytene chromosomes were incubated with 100 μg/ml of RNase A in TKM buffer for 60 min at room temperature immediately after isolation. The RNase A--treated chromosomes were then rinsed in TKM, postfixed, and incubated with primary and secondary antibodies as described above.

For immunocytological analysis, the isolated chromosomes were blocked with 50 μl of 2% BSA in TKM for 30 min at room temperature in a humid chamber and incubated for 45 min with 40 μl of undiluted 1D3 hybridoma supernatant or 40 μl of the negative control mouse monoclonal anti--factor VIII antibody (DAKO A/S) diluted 1:50 in TKM. The slides were washed three times for 5 min in 0.1% Tween-20 in TKM and incubated for 90 min with 50 μl of the gold-conjugated secondary antibody (Jackson ImmunoResearch Laboratories, West Grove, PA; IgG, 6 nm in diameter) diluted 1:50 in TKM containing 0.5% BSA. The specimens were washed three times for 5 min in TKM and with distilled water, an immunogold silver enhancement solution (IntenSEM; Amersham Corp., Buckinghamshire, England) was added onto the specimens for 8--10 min at room temperature, and the specimens were rinsed in distilled water, mounted in 30% glycerol, and examined and photographed in a light microscope (Carl Zeiss, Inc., Thornwood, NY).

Isolation of 1D3-specific cDNA Clones
-------------------------------------

The hybridoma culture supernatant containing mAb 1D3 was diluted 1:100 to screen a randomly primed λgt11 *C*. *tentans* salivary gland cDNA library by the ProtoBlot Immunoscreening System (Promega Corp.). Two antibody-specific clones were purified and sequenced. One of them, pHRP23.1, was used as template for PCR amplification with λgt11 forward and reverse primers (Promega Corp.). The amplified DNA fragment was purified by the Wizard™ PCR Preps DNA Purification Kit and labeled by the DIG DNA Labeling and Detection Kit (Boehringer Mannheim GmbH, Mannheim, Germany). The labeled probe was used to screen an oligo dT--primed λZAP cDNA library from the salivary glands of *C*. *tentans* following the manufacturer\'s instructions. 10 positive clones were obtained and purified for sequence analysis.

DNA Sequencing and Sequence Analysis
------------------------------------

The cDNA inserts of positive clones were amplified by PCR. The purified DNA fragments were used for sequencing with walking primers. The Taq DyeDeoxy™ Terminator Cycle Sequencing Kit (PE Applied Biosystems, Warrington, GB) was applied for the sequence reaction and sequencing gel was run on an automated DNA sequencer (model 373A; PE Applied Biosystems). The DNA sequences were analyzed with the University of Wisconsin Genetics Computer Group Sequence Analysis Programs ([@B18]) and EGCG extensions to the Wisconsin Package Sequence Analysis Programs.

Expression of hrp23 and Identification of Expression Product
------------------------------------------------------------

The hrp23 protein was expressed according to the Promega protocol for expression of lambda lysogen in preparative amounts. The *E*. *coli* Y1089 were infected with a λgt11 clone, pHRP23.1, containing hrp23 cDNA, and the presence of the hrp23 sequence insert was confirmed by PCR using inner primers. Half of the bacterial culture was IPTG-induced, while the other half served as control. Both cultures were lysed in 2× sample buffer at 95°C for 5 min, and the supernatants were analyzed with SDS-PAGE and Western blotting as described above with a few modifications. The electrophoresis was performed in 12% polyacrylamide gels. The 1D3 hybridoma supernatant was diluted 1:100. The membrane was subjected to ECL (Amersham Corp.) according to the manufacturer\'s instructions using a peroxidase-conjugated goat anti--mouse immunoglobulin (DAKO A/S) diluted 1:500 in PBS provided with 0.1% Tween.

Alkaline Phosphatase Treatment of RNP Extract
---------------------------------------------

The RNP extract was divided into two equal portions: one was treated with 250 U/ml of calf intestine alkaline phosphatase (Boehringer Mannheim GmbH) for 30 min at 37°C and the other in parallel with no enzyme added but with 5 mM β-glycerophosphate. The protein was precipitated with acetone and resuspended for SDS-PAGE as described above.

Immunocytology on Cryosections
------------------------------

Immunostaining on semithin cryosections of tissue culture cells and salivary glands was performed as previously described ([@B78]). When *C*. *tentans* tissue culture cells were used, the cells were washed once in PBS and collected as a pellet. The cell pellet and salivary glands were fixed for 45--60 min in 4% formaldehyde in 0.1 M cacodylate buffer, pH 7.2, at room temperature. The fixed pellet and salivary glands were cryoprotected with 2.3 M sucrose and frozen by immersion in liquid nitrogen. Semithin sections (0.5 μm) were obtained in a cryo-ultramicrotome (Ultracut S/FC S; Reichert-Jung, Vienna, Austria) and mounted on glass slides. Before immunolabeling, the sections were incubated in PBS containing 0.1 M glycine and 2% BSA. As first antibody, we used either undiluted 1D3-hybridoma supernatant or 20 μg/ml anti--factor VIII antibody (negative control). In the second step of the immunostaining, we used an antibody against mouse IgG conjugated to 6-nm gold particles (Amersham Corp.). The immunogold labeling was silver-enhanced with IntenSE™ M (Amersham Corp.).

Immunoelectron Microscopy
-------------------------

Immunoelectron microscopy was essentially carried out according to the method described by [@B75] with a few modifications ([@B78]). The specimens were prepared as described above for light microscopy except that fixation was performed for 20--25 min in 4% formaldehyde and 0.1% glutaraldehyde. Ultrathin cryosections were picked up on drops of 2.3 M sucrose and deposited on nickel grids coated with formvar and carbon. The grids were floated on drops of PBS containing 10% new born calf serum before incubation with the antibody solutions. The same antibodies as described above under "Immunocytology on Cryosections" were used. After immunolabeling, the sections were stained with 2% aqueous uranyl acetate and embedded in 4% polyvinyl alcohol (9--10 kD; Aldrich Chemical Co., Milwaukee, WI). The specimens were examined and photographed in a microscope (model 100 CX; JEOL U.S.A., Peabody, MA) at 80 kV.

Results {#Results}
=======

Generation and Selection of a Monoclonal Antibody against a 23-kD hnRNP Protein in C. tentans
---------------------------------------------------------------------------------------------

Monoclonal antibodies were raised against hnRNP proteins immunoprecipitated from a *C*. *tentans* nuclear RNP extract. *C*. *tentans* tissue culture cells were homogenized, and the intact nuclei were collected and used for preparation of the RNP extract as described by [@B80]. The RNP extract contained a large number of proteins as shown by SDS-PAGE (Fig. [1](#F1){ref-type="fig"} *a*, lane *1*). The hnRNP complexes were immunoprecipitated from the RNP extract by a two-step procedure, using a monoclonal antibody against hnRNP protein hrp36 (mAb 4F9) and an anti--mouse immunoglobulin coupled to protein A--Sepharose. The bound proteins were eluted, precipitated, and subjected to SDS-PAGE (Fig. [1](#F1){ref-type="fig"} *a*, lane *2*). The immunoprecipitation resulted in a less complex protein pattern suitable for production of monoclonal antibodies.

The immunoprecipitated proteins were used to immunize BALB/c mice according to the standard procedure. Several major proteins in the nuclear extract reacted with mouse sera in Western blots (Fig. [1](#F1){ref-type="fig"} *b*, lane *1*). The spleen cells of the immunized mouse were fused with mouse myeloma Sp20 cells, and hybridoma clones were selected with a standard hypoxanthine-aminopterin-thymidine (HAT) procedure. Positive clones were identified by screening hybridoma supernatants against the *C*. *tentans* RNP extract in Western blot experiments ([@B80]). The supernatant of one hybridoma clone, 1D3, showed high affinity for a 23-kD protein in the *C*. *tentans* nuclear RNP extract (Fig. [1](#F1){ref-type="fig"} *b*, lane *2*); the same result was obtained with a *C*. *tentans* cytoplasmic extract (data not shown). No bands were detected in the control lane with the anti--factor VIII antibody (Fig. [1](#F1){ref-type="fig"} *b*, lane *3*). Furthermore, in preliminary chromosome squash experiments, the 1D3 antibody reacted with the BRs (data not shown). On the basis of these experiments, we selected the 1D3 clone for further experiments and designated the corresponding 23-kD protein Ct-hrp23 (or hrp23, for short), following earlier established nomenclature for hnRNP proteins in *Diptera* ([@B43]; [@B80]).

hrp23 Is Present in BRs, Other Chromosomal Puffs, and in Nucleoli
-----------------------------------------------------------------

To determine the chromosomal distribution of hrp23, we performed immunolabeling experiments on isolated polytene chromosomes. The chromosomes were isolated from prefixed salivary glands, immunolabeled with mAb 1D3 (or anti--factor VIII antibody as control), visualized by a gold-conjugated secondary antibody, and silver enhanced. The 1D3 antibody reacted strongly with the large BRs on chromosome IV (Fig. [2](#F2){ref-type="fig"} *a*). However, smaller puffs were also immunostained as seen both on chromosome IV (Fig. [2](#F2){ref-type="fig"} *a*) and chromosome III (Fig. [2](#F2){ref-type="fig"} *c*). In addition, it was noted that nucleoli stained with 1D3 (Fig. [2](#F2){ref-type="fig"} *c*). The staining of BRs, minor puffs, and nucleoli was sensitive to RNase (not shown). The negative control did not exhibit any significant staining (Fig. [2](#F2){ref-type="fig"}, *b* and *d*). In conclusion, the hrp23 protein is likely to be present in BRs, a large number of additional, smaller chromosomal puffs, and in the two nucleoli. As the immunostaining is sensitive to RNase, it is suggested that hrp23 is a protein associated with RNA.

cDNA Cloning of hrp23
---------------------

By screening cDNA libraries prepared from *C*. *tentans* salivary glands, the full cDNA sequence for hrp23 was found. First, the 1D3 antibody was used to screen a randomly primed λgt11 cDNA library made from salivary glands of *C*. *tentans*. Two antibody-specific clones were isolated and sequenced. One of the clones, pHRP23.1, was used to synthesize a DNA probe by PCR amplification. The probe was labeled with digoxigenin and used to screen an oligo(dT)-primed λZAP cDNA library made from salivary glands. 10 positive clones were found and sequenced (see below). All clones had the same coding sequence; no variant was found in spite of extensive screening of the salivary gland cDNA libraries.

To demonstrate that the protein, encoded in the cDNA clone, is indeed recognized by 1D3 in the RNP extract, a crude lysate containing the hrp23 recombinant protein was prepared by expressing the desired λ lysogen in *Escherichia coli*. The expressed protein was then compared with the native hrp23 protein extract by Western blot analysis using the 1D3 antibody and the ECL detection system. In the extract from the induced bacteria, the 1D3 antibody recognized a prominent protein fraction corresponding to an apparent molecular mass of 23 kD (Fig. [3](#F3){ref-type="fig"}, lane *4*). A very weak band at the same position was seen in the noninduced bacteria, probably because of leaky expression of the lysogen (Fig. [3](#F3){ref-type="fig"}, lane *3*). The recombinant protein migrated somewhat more rapidly than hrp23 in the RNP extract from *C*. *tentans* tissue culture cells (Fig. [3](#F3){ref-type="fig"}, lane *1*). When the RNP extract was treated with alkaline phosphatase, this discrepancy disappeared (Fig. [3](#F3){ref-type="fig"}, lane *2*). We conclude that the recombinant protein reacts with the 1D3 antibody and has the expected apparent molecular mass of hrp23. In addition, it is inferred that the native hrp23 protein is likely to be phosphorylated, which has been further supported by phosphate labeling experiments in vivo (Aissouni, Y., and B. Daneholt, unpublished results).

The cDNA Sequence of hrp23
--------------------------

The hrp23 protein contains 191 amino acids, and the predicted molecular mass is 20 kD, which is somewhat smaller than the apparent molecular mass in SDS-PAGE (23 kD). hrp23 has a modular structure like other hnRNP proteins: there is an NH~2~-terminal RNA-binding domain containing the RNP-1 and RNP-2 consensus sequences, and a COOH-terminal auxiliary domain rich in glycine (37%), arginine (21%), and serine (16%) (Fig. [4](#F4){ref-type="fig"}). It should be noted that the auxiliary domain contains clustered glycines, three Arg-Gly-Gly (RGG) tripeptides, and eight Arg-Ser or Ser-Arg dipeptides.

The hrp23 protein was compared with other RNA-binding proteins using the EMBL data base ([@B63]) and the Swiss-PROT data base ([@B4]). A *Drosophila* protein, ROX21 ([@B10]), proved to be very similar to hrp23; the amino acid identity between the two proteins amounts to 74% in the RBD domain and to 48% in the auxiliary domain (Fig. [5](#F5){ref-type="fig"}). Furthermore, hrp23 (and ROX21) shares major features with several RNA-binding proteins in mammals, insects, and plants, which contain one or two NH~2~-terminal RBDs and a COOH-terminal auxiliary domain.

The glycine-rich auxiliary domain of hrp23 prompted comparisons between hrp23 and a subgroup of hnRNP proteins, the RBD-Gly RNA-binding proteins. These proteins contain one or two NH~2~-terminal RBDs and a glycine-rich COOH-terminal domain (for reviews see [@B8]; [@B20]). The RBD-Gly proteins with one RBD comprise RBM3 ([@B17]) and hnRNP G ([@B72]) in human and a series of exceptionally Gly-rich proteins in plants (for references see [@B6]; [@B77]). The RBD-Gly proteins with two RBDs include hnRNP A1 ([@B12]) and hnRNP A2/B1 ([@B11]) in human, hrp 36/38, hrp40, and hrp48 in *Drosophila* ([@B30], [@B31]; [@B43]), and hrp36 in *Chironomus* ([@B78]). The hrp23 and the RBD-Gly proteins all have a typical RBD with the RNP-1 and RNP-2 submotifs, and the amino acid sequence identity between the RBD of hrp23 and that of the others is in the range of 21--37%. The auxiliary domains of hrp23 and the RBD-Gly proteins display the same basic structure: clustered glycine residues being interspersed with arginine and aromatic amino acids. The sequence RGG (GRG or GGR) is also a characteristic feature. In hrp23, the aromatic amino acid is phenylalanine, while in most of the others it is tyrosine. The auxiliary domain of hrp23 shows a sequence identity of 25--39% with that of the other nonplant proteins and as high as 41--45% with the exceptionally glycine-rich (∼70%) auxiliary domains of the plant proteins. However, it should be recalled that it is difficult to compare glycine-rich domains with each other because of the very low sequence complexity ([@B8]). We conclude that hrp23 has features in common with the RBD-Gly proteins: the RBD is similar, and the auxiliary domain is glycine-rich with RGG repeats and interspersed aromatic acids.

The presence of several RS/SR dipeptides in the auxiliary domain of hrp23 necessitated comparisons between hrp23 and the SR protein family, the members of which contain one or more RBDs and an auxiliary RS domain. In SR proteins, the RS domain is characterized by a large number of RS/SR dipeptides, often in clustered arrangements. The following three SR proteins, all with one RBD and a molecular mass of ∼20 kD, showed the strongest similarities to hrp23: SRp20 ([@B3]; [@B82]) and 9G8 ([@B14]) from human and RBP1 from *Drosophila* ([@B35]). The RBD region of hrp23 is 46, 49, and 41% identical to the RBD region of SRp20, 9G8, and RBP1, respectively; the RNP-1 and RNP-2 submotifs are perfectly conserved in the four proteins. Furthermore, when comparisons were made between the corresponding auxiliary domains, the following figures were obtained: 29, 25, and 41% sequence identity, respectively. The SR/RS dipeptides are, however, fewer (8) in hrp23 than in the three small SR proteins (12--31), and the dipeptides in hrp23 are interspersed rather than clustered. Furthermore, the monoclonal antibody mAb104, which is known to recognize a phosphoepitope in the RS domain of SR proteins ([@B66]), does not react with hrp23 (data not shown). We conclude that hrp23 resembles the SR proteins, as its RBD is strikingly similar to that of the SR proteins and its auxiliary domain of hrp23 contains several SR/RS dipeptides, but it is also evident that hrp23 does not fulfill all the criteria for a typical SR protein.

In summary, hrp23 is an RNA-binding protein with a single NH~2~-terminal RBD and a COOH-terminal auxiliary domain rich in glycine, arginine, and serine. The hrp23 has a homologous counterpart in the *Drosophila* protein ROX21, and it shares important features with both RBD-Gly proteins and SR proteins (see Discussion).

hrp23 Is Mainly Located in the Nucleus
--------------------------------------

To reveal the intracellular distribution of hrp23, the salivary glands were studied with immunocytology. Semithin sections of salivary glands were incubated with the 1D3 antibody and subsequently with a gold-conjugated secondary antibody. The labeling was examined after silver enhancement. The nuclei of the salivary glands were heavily immunostained (Fig. [6](#F6){ref-type="fig"}, *a* and *b*). Puffs and nucleoli (cf., Fig. [2](#F2){ref-type="fig"}) were decorated by the antibody as well as the nucleoplasm surrounding the polytene chromosomes. The cytoplasm was weakly stained (Fig. [6](#F6){ref-type="fig"}, *a* and *b*). In the control (Fig. [6](#F6){ref-type="fig"} *c*), no immunostaining could be detected either in the nucleus or in the cytoplasm; the negative control is also shown in phase contrast (Fig. [6](#F6){ref-type="fig"} *c′*). We conclude that hrp23 is mainly located in the nucleus and that hrp23 is present both on the polytene chromosomes and in the surrounding nucleoplasm.

hrp23 Is Present in Growing and in Nucleoplasmic BR RNP Particles but Is Absent from the BR Particles Bound to the Nuclear Pore Complex
---------------------------------------------------------------------------------------------------------------------------------------

Immunoelectron microscopy was used to investigate the behavior of hrp23 in relation to the assembly and transport of BR pre-mRNP particles. Salivary glands were fixed and frozen, and ultrathin cryosections were prepared. The sections were incubated with antibodies, stained with aqueous uranyl acetate, and embedded in polyvinyl alcohol. The specimens were examined and photographed in a transmission electron microscope.

The immunoelectron microscopy analysis was focused on the giant puffs, the BRs. The active genes appear as chromosomal loops, along which the growing BR RNP particles can be analyzed. In a single section, examples of promoter-proximal (*p*), middle (*m*), and promoter-distal (*d*) portions of the BR genes can be discerned (Fig. [7](#F7){ref-type="fig"} *a*). In the proximal region, the RNP products appear as short thick fibers, while further downstream the gene, they can be described as stalked granules. This conformational change is due to the fact that the RNP fiber is being packed into a globular structure, which gradually increases in diameter along the course of transcription (for more detailed description see [@B36]).

As shown in Fig. [7](#F7){ref-type="fig"} *a*, growing RNP particles in all three segments of the BR gene are labeled with gold (cf., the complete absence of gold particles in the control in Fig. [7](#F7){ref-type="fig"} *f*). Thus, the hrp23 protein is being added to the BR transcript concomitant with transcription. The BR RNP particles can be seen released into the nucleoplasm (Fig. [7](#F7){ref-type="fig"} *b*), and when they pass through the nuclear pore after having changed from a globular to a more extended conformation (Fig. [7](#F7){ref-type="fig"}, *c* and *d*). Beneath the electron micrographs of the nucleoplasmic and translocating particles, we have outlined the particles in schematic drawings, where also the nuclear envelope is indicated (Fig. [7](#F7){ref-type="fig"}, *b′--d′*). Most of the nucleoplasmic particles are decorated by gold (Fig. [7](#F7){ref-type="fig"}, *b--d*, *arrows*), while no gold is seen associated with the translocating particles. To further substantiate this point, we carried out a semiquantitative analysis. 400 nucleoplasmic particles were scrutinized, and 62% of them were labeled (242/400). We recorded 17 well-defined translocating particles, none of them labeled. Thus, hrp23 seems to be present in the nucleoplasmic particles, also in those close to the nuclear envelope, but once the BR particles become attached to the nuclear pore complex and translocate through the pore, the hrp23 protein is absent. In conclusion, the hrp23 protein is bound to the BR RNA concomitant with transcription, remains bound to the released BR RNA particles in the nucleoplasm, but is released from the particle before or at the binding of the particle to the nuclear pore complex for further exit into the cytoplasm.

The hnRNP particles present in chromosomal puffs other than the BRs are also decorated with gold (data not shown) (cf., the immunostaining of smaller puffs in Fig. [2](#F2){ref-type="fig"}, *a* and *c*). When released into the nucleoplasm, they often appear in a more or less fibrous conformation and can be seen immunolabeled (Fig. [7](#F7){ref-type="fig"} *c*). Therefore, hrp23 seems also to associate with non--BR hnRNA during transcription, and it presumably stays with the RNA after its release into the nucleoplasm. Whether hrp23 is shed before the nucleocytoplasmic transport of the RNA cannot be decided in this case, as the non-BR hnRNP complexes cannot be recognized as well-defined entities when passing through the nuclear pores.

In the cytoplasm, the density of labeling was low, but it was significantly higher than in the negative control (Fig. [7](#F7){ref-type="fig"}, *e* vs. *f*). The gold particles were seen scattered in the cytoplasm between or close to the tubules of the endoplasmic reticulum (Fig. [7](#F7){ref-type="fig"} *e*). Thus, a small amount of hrp23 can be detected in the cytoplasm. One possible interpretation would be that the low level of labeling corresponds to nascent and newly synthesized hrp23, but other explanations are conceivable (see further Discussion).

hrp23 Is Present in the Nucleolus
---------------------------------

The analysis of immunolabeled polytene chromosomes revealed that hrp23 is present in the nucleoli of salivary gland cells. This result was confirmed and extended with immunoelectron microscopy. Fig. [8](#F8){ref-type="fig"} *a* shows a segment of a nucleolus with its fibrillar (*F*) and granular (*G*) regions indicated. A small region (*square*) is presented at a higher magnification in Fig. [8](#F8){ref-type="fig"} *b*. Gold particles appeared in both the fibrillar and granular compartments (Fig. [8](#F8){ref-type="fig"} *b*, *arrows*), while no labeling could be visualized in the negative control (Fig. [8](#F8){ref-type="fig"} *c*). As the labeling of nucleoli is RNase sensitive, we conclude that hrp23 is probably associated with RNA in the nucleolus, but the nature of this RNA remains to be determined.

hrp23 Is Likely to be a Nonshuttling Protein
--------------------------------------------

To analyze whether hrp23 behaves as a shuttling protein in *C*. *tentans*, we performed an actinomycin D experiment as devised by [@B59]. In this type of experiment shuttling, but not nonshuttling, proteins will accumulate in the cytoplasm. *C*. *tentans* tissue culture cells were incubated for 1 h with actinomycin D in the presence of cycloheximide, fixed, sectioned, and challenged with antibodies; untreated cells were analyzed in parallel. The hrp36 protein served as control representing the behavior of a shuttling protein. The hrp23 protein was recorded mainly in the nucleus in both treated and untreated cells (Fig. [9](#F9){ref-type="fig"}). Thus, no accumulation of hrp23 in the cytoplasm was detected. In the control, the shuttling protein hrp36 shifted from the nucleus to the cytoplasm during the drug experiment (Fig. [9](#F9){ref-type="fig"}). This result shows that hrp23 is not a transcription-dependent shuttling hnRNP protein and indicates that it is a nonshuttling protein. This is in good agreement with the observation that hrp23 is shed from the BR particles before the translocation of the particles through the nuclear pores.

Discussion {#Discussion}
==========

Functional Implications of the Structure of the hnRNP Protein hrp23
-------------------------------------------------------------------

The hrp23 protein contains a single NH~2~-terminal RNA-binding domain and a COOH-terminal domain rich in glycine, arginine, and serine. There is a recently described homologue in *Drosophila*, the ROX21 protein ([@B10]). Furthermore, sequence comparisons with RNA-binding proteins revealed that hrp23 is similar to the RBD-Gly proteins as well as to the SR proteins, all exhibiting one or two NH~2~-terminal RBDs and an auxiliary domain. In particular, the presence of clustered glycine residues, RGG repeats, and an interspersed aromatic amino acid (phenyalanine) in the auxiliary domain makes hrp23 appear similar to the RBD-Gly RNA-binding proteins with their glycine-rich auxiliary domain. However, the RBD in hrp23 shows a strikingly high (∼45%) identity to the RBD of low molecular weight SR proteins, and the auxiliary domain in hrp23 contains several SR/RS dipeptides. It seems, therefore, as if hrp23 and its *Drosophila* homologue ROX21 represent a group of proteins intermediate in structure between the RBD-Gly proteins and the SR proteins, which suggests that there is not a sharp boundary between these two groups of hnRNP proteins.

RGG-rich domains are present in a large number of proteins involved in various aspects of RNA metabolism, such as pre-rRNA processing, pre-mRNA splicing, and RNA helicase activity (for references see [@B74]; [@B34]). It is interesting to note that in hnRNP U protein, which lacks an RBD, a single COOH-terminal RGG-rich region, termed the RGG box, is known to be sufficient for RNA binding ([@B34]). Likewise, a COOH-terminal fragment of nucleolin, containing an RGG-box like domain, is also able to independently accomplish binding to RNA ([@B28]). Furthermore, in hnRNP A1, the RGG-rich domain acts in a cooperative manner as to RNA binding with the two RBDs ([@B37]). It is therefore possible that the RGG-containing auxiliary domain in hrp23 also promotes binding of the protein to the pre-mRNA molecule and perhaps also affects the specificity of the binding to the RNA.

The SR proteins are known to act as splicing factors in both in vitro and in vivo experiments (for review see [@B25]). For all three SR proteins most closely related to hrp23, it has been demonstrated that they can function as splicing factors. The RBP1 protein in *Drosophila* can both activate splicing and switch splice site selection in in vitro experiments ([@B35]). The human 9G8 protein is an essential splicing factor as also shown in experiments in vitro ([@B14]). Finally, [@B67] could demonstrate in vivo that the human SRp20 protein can regulate alternative splicing. Thus, it seems as if this group of SR proteins is essential for splicing and can modulate alternative splicing, but it remains to be proven whether also hrp23 acts as a splicing factor.

hrp23 and Transport of BR RNP Particles
---------------------------------------

The hrp23 protein is added to BR pre-mRNA concomitant with transcription. It is present in the proximal, middle, and distal regions of the active gene. The protein is, therefore, added early during the transcription process, and most likely also along the entire BR transcript like the other two hnRNP proteins earlier studied, hrp36 ([@B36]) and hrp45 ([@B1]). It should be noted that concomitant with transcription, spliceosomes rapidly assemble and disassemble on the 5′ region of the transcript and start to assemble at the 3′ end of the transcript, leaving the middle section of the gene devoid of spliceosome components ([@B36]). As hrp23 remains bound to the growing RNP particles all during transcription, hrp23 is not likely to be a true spliceosomal component. This is further supported by the observation that hrp23 is present in the released nucleoplasmic BR particles, the vast majority of which contain fully spliced BR RNA and no spliceosome components like snRNP. These results do not rule out the possibility that hrp23 is involved in splicing. However, if so, hrp23 (like the SR protein hrp45) should exert its action as a structural component of the elementary RNP fiber in the BR particles.

The nucleoplasmic BR particles are frequently labeled in the immunoelectron microscopy experiment; more than half of them are decorated with gold. This is a high figure considering that all particles are not likely to be accessible to the antibodies in the sections because of steric hindrance. It is then a striking observation that no BR particles have been seen immunolabeled when bound to the nuclear pore complex or when translocating through the central channel of the complex. Evidently, hrp23 is released from the BR particle just before the binding of the particle to the pore complex or in conjunction with the binding. It can be speculated that the shedding of hrp23 could even be a prerequisite for binding. It should be noted that this behavior of hrp23 is different from that of the SR protein hrp45. This protein is present on the particle at the pore (translocating particles are immunolabeled to almost the same extent as nucleoplasmic particles), but it is discarded when the RNP particle changes conformation and is entering the central channel, indicating that this SR protein could be linked to the translocation per se ([@B1]).

The hrp23 protein does not seem to leave the nucleus and should therefore be classified as a nonshuttling protein. This was further substantiated in the present study by an actinomycin D experiment performed with *C*. *tentans* tissue culture cells according to [@B59]. It was not possible to translocate the nuclear hrp23 into cytoplasm during the drug treatment, while the shuttling protein hrp36 analyzed in parallel accumulated in the cytoplasm. This result suggested that not only is the hrp23 bound to BR RNP particles confined to the nucleus, but so is the hrp23 in all hnRNP particles. It should, however, be recalled that a shuttling experiment could be misleading because some hnRNP proteins, e.g., Npl3 in yeast ([@B38]), only shuttle in the presence of on-going transcription.

A small amount of hrp23 was detected in the cytoplasm in the immunocytology and in the immunoelectron microscopy experiments. The explanation closest at hand is that the low immunosignal corresponds to nascent and newly synthesized hrp23. However, considering the small size of hrp23, it is also possible that free hrp23 can diffuse through the nuclear pore and appear in the cytoplasm; proteins below 40--60 kD are able to do so ([@B58]). Finally, we cannot exclude, although we regard it as less likely, that a low amount of hrp23 is transported from the nucleus to the cytoplasm as part of an RNP complex originating from one or more of the smaller chromosomal puffs or from the nucleoli.

When the behavior of hrp23 is considered in relation to the total information available on the transport of BR particles in the salivary gland cells, a dynamic picture emerges. Until now, the following components have been studied during the assembly and transport of the BR particles: snRNP proteins ([@B36]), the cap-binding protein CBP20 ([@B79]), hrp36 ([@B78]), hrp45 ([@B1]), and now also hrp23. Each of these proteins displays its own specific behavior. The snRNP proteins show a transient association with the particle during splicing, while the CBP20 is added to the 5′ end of the transcript early during transcription and is not released until the 5′ end hits the cytoplasm. The three hnRNP proteins are all added onto and along the transcript concomitant with transcription. While hrp36, an A1-like protein, accompanies the BR RNA through the pores into cytoplasm and even into polysomes, hrp23 and hrp45 remain in the nucleus. The hrp23 protein is, however, clearly shed before or at the binding of the particle to the pore complex, while hrp45 is not displaced until the RNP is entering the central channel of the pore complex. Thus, the two nonshuttling proteins studied are not released at the same time in conjunction with the translocation of the BR particle through the nuclear pore, but do so in a consecutive fashion beginning before or at the binding of the particle to the nuclear pore complex. The finding that the BR RNA-binding proteins hrp23, hrp36, and hrp45 behave differently during nucleocytoplasmic transport suggests that each of them could play a specific role during the export of mRNA from the nucleus to the cytoplasm.

hrp23 Appears in the Nucleolus
------------------------------

It was surprising to find that the hrp23 protein is present in the nucleolus. It resides evidently both in the fibrillar and granular regions of the nucleolus. One hnRNP protein, hnRNP I, has earlier been detected in a discrete perinucleolar region ([@B27]), but hrp23 is the first hnRNP protein found to be located within the nucleolus. As the hrp23 immunolabeling was shown to be sensitive to RNase, it is likely that hrp23 is associated with RNA. One possibility would be that hrp23 is bound to ribosomal RNA, either one or more of the RNA species generated in the nucleolus or 5S RNA transported from the site of synthesis to the nucleolus. A second possibility would be that hrp23 is coupled to a nonribosomal RNA species. Typical, DRB-sensitive hnRNA has not been recorded in the nucleolus, but a rapidly labeled, DRB-insensitive, heterodisperse RNA in the 20--30 S size range has been revealed ([@B65]). If this specific type of putative hnRNA would be associated with hrp23, neither hrp36 nor hrp45 would be part of the RNP complex. Such a nucleolus-located hnRNP complex would then be a striking example of the concept that each type of hnRNP particle contains a specific subset of hnRNP proteins ([@B44]; [@B80]).
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![Generation and characterization of monoclonal antibody 1D3. (*a*) SDS-PAGE of the proteins in the RNP extract from *C*. *tentans* tissue culture cells (lane *1*), and of the proteins immunoprecipitated from the RNP extract by mAb 4F9 and used for subsequent immunization of BALB/c mice (lane *2*). The protein recognized by mAb 4F9, hrp36, is indicated with an asterisk at lane *2*. The position of molecular mass standards is shown to the left in kilodaltons. (*b*) Western blot analysis of the RNP extract probed with serum from an immunized mouse (lane *1*), mAb 1D3 (lane *2*), and negative control antibody (lane *3*). The molecular mass standards are the same as in *a*.](JCB9804084.f1){#F1}

![Immunolocalization of hrp23 on isolated *C*. *tentans* polytene chromosomes. The chromosomes were isolated from prefixed salivary glands and incubated with monoclonal antibody 1D3 (*a* and *c*) or with an anti--factor VIII antibody as negative control (*b* and *d*). The antibody-binding sites were visualized by a gold-conjugated secondary antibody and silver enhancement. Examples of chromosome IVs (*a* and *b*) and chromosomes IIIs (*c* and *d*) are shown. The positions of BR1, BR2, and nucleolus (*Nu*) have been indicated. Bar, 10 μm.](JCB9804084.f2){#F2}

![Western blot comparison of hrp23 from *C*. *tentans* tissue culture cells with hrp23 expressed in *E*. *coli*. The extracted proteins were separated by SDS-PAGE, blotted onto transfer membranes, and probed with mAb 1D3. Lane *1*, RNP extract from tissue culture cells. Lane *2*, alkaline phosphatase--treated RNP extract from tissue culture cells. Lane *3*, extract from *E*. *coli*, containing the hrp23 cDNA clone, before IPTG induction. Lane *4*, extract from *E*. *coli*, containing the hrp23 cDNA clone, after IPTG induction. The positions of two molecular mass standards are indicated to the left.](JCB9804084.f3){#F3}

![Nucleotide sequence and deduced amino acid sequence of the hrp23 cDNA clone pHRP23.2. This HRP clone was the longest one recorded and sequenced. The RBD is boxed. Within RBD, the two most highly conserved sequence elements, RNP-1 (*solid line*) and RNP-2 (*dashed line*) are underlined. The end of the coding region is indicated by an asterisk. These sequence data are available from the EMBL DNA data base under accession number [AJ003820](AJ003820).](JCB9804084.f4){#F4}

![Primary structure comparison of hrp23 with *Drosophila* Rox21 protein. The two complete amino acid sequences are aligned and presented by the PILEUP and PRETTYPLOT programs. Regions with sequence similarity are boxed. Gaps in the alignment are shown by dashes.](JCB9804084.f5){#F5}

![Immunocytological localization of hrp23 in *C*. *tentans* salivary gland cells. Semithin cryosections of salivary glands were treated with mAb 1D3 (or with a negative control antibody), a gold-conjugated secondary antibody was added, and the antibody binding was visualized by silver enhancement. The 1D3-treated specimens are shown in bright field (*a* and *b*), and the negative controls are shown in bright field (*c*) and phase contrast (*c′*). The nuclei (*NUC*), cytoplasm (*CYT*), and gland lumen (*LUM*) are indicated. Bars, 40 μm.](JCB9804084.f6){#F6}

![Immunoelectron microscopic localization of hrp23 in *C*. *tentans* salivary gland cells. Thin cryosections were incubated with mAb 1D3 (*a--e*), or with a negative control antibody (*f*), and a gold-conjugated secondary antibody was used to visualize the labeled sites. (*a*) Proximal (*p*), middle (*m*), and distal (*d*) segments of transcriptionally active BR genes. (*b--d*) Nucleoplasmic BR particles close to the nuclear envelope (*arrows*) and extended BR particles translocating through the nuclear pores. Schematic interpretations of the electron micrographs are shown beneath (*b′--d′*). The nucleus (*N*) is located above the nuclear envelope, and cytoplasm (*C*) is located beneath. The non--BR hnRNP complexes appear in the nucleoplasm as an irregular fibrous network labeled with a few gold particles (*c*). (*e*) Cytoplasm containing tubular ER with associated ribosomes. The arrows point at gold particles. (*f*) The negative control showing nuclear envelope with adjacent nuclear (*N*) and cytoplasmic (*C*) regions. In the nucleus, growing BR RNP particles can be discerned (cf., *a*). Bar, 100 nm.](JCB9804084.f7){#F7}

![Immunoelectron microscopic localization of hrp23 in the nucleolus of *C*. *tentans* salivary glands. Semithin sections through a nucleolus in a salivary gland cell were treated with mAb 1D3, and the binding was visualized by a gold-conjugated secondary antibody. In parallel, sections were incubated with a negative control antibody. (*a*) A segment of a nucleolus, with its fibrillar (*F*) and granular (G) compartments, and the surrounding nucleoplasm (*NP*). (*b*) The area demarcated with a rectangle in *a*, at higher magnification. The arrows denote the position of gold particles. (*c*) The negative control. Bars: (*a*) 250 nm; (*b* and *c*) 100 nm.](JCB9804084.f8){#F8}

![Transcription-independent nuclear localization of hrp23. *C*. *tentans* tissue culture cells were treated for 1 h with (*act D*) or without (*normal*) actinomycin D in the presence of cycloheximide. To locate hrp23, semithin cryosections were incubated with mAb 1D3 and subsequently with a gold-conjugated secondary antibody. The labeling was visualized by silver enhancement and photographed in bright field. The distribution of the shuttling protein hrp36 was analyzed in parallel with mAb 4F9. Some of the immunopositive nuclei have been indicated by arrows. Bar, 25 μm.](JCB9804084.f9){#F9}
